ज्यादा पढ़ी गई:
The Exchange has sought clarification from Natco Pharma Ltd on February 24 2026 with reference to news appeared in https://www.livemint.com dated February 24 2026 quoting "Eris Lifesciences inks deal with Natco Pharma for weight-loss drug semaglutide."
The reply is awaited.
Disclaimer: यह कंटेंट सिर्फ़ जानकारी के लिए है और इसे निवेश सलाह या रेकमेंडेशन नहीं मानना चाहिए.
शिकायतों के लिए संपर्क करें: [email protected]
वैल्यू रिसर्च से पूछें 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
